Forest Laboratories' Namenda Is Focus of Lawsuit

The state attorney general said Actavis’s plan to stop selling an older tablet in favor of a newer one was an attempt to maintain a monopoly.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Forest Laboratories Inc FRX NYSE Drugs (Pharmaceuticals) Suits and Litigation (Civil) Warner Chilcott Ltd WCRX NASDAQ Antitrust Laws and Competition Issues New York State Walgreen Company WAG NYSE Actavis Abbott Laboratories ABT NYSE Gen Source Type: news